PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria

Sponsor
Ahmadu Bello University
Study ID
NCT07733440
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Africa
  • Algorithms
  • Biomarker
  • Clinical Decision Support Systems
  • Community Health Services
  • Evidence-Based Practice
  • Global Health
  • Implementation Research
  • Models
  • Nigeria
  • Predictive Value of Tests
  • Primary Health Care
  • Prostate Cancer
  • Prostate Specific Antigen
  • Risk Assessment

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • (a) Training and (b) Supported risk assessment — OTHER
    1. The training intervention will be facilitated by experienced clinical mentors through didactics and demonstrations and conducted as half-day sessions over 3 days 2. This intervention includes risk calculator use and clinical mentorship for at least six months.

Study Details

This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population. The main questions the validation study aims to answer are: 1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer? 2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer? The main questions the intervention study aims to answer is: Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement? The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes

Key Dates

First listed
Jul 29, 2026
Start date
Mar 31, 2029
Status verified
Jul 2026
Primary completion
Aug 31, 2029
Completion
Aug 31, 2029

Study Design

Enrollment
89 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Other: Training and Supported risk assessment

Primary Outcome Measure

Task completion rate [ Time Frame: 6 months ]

Central Contacts

Find similar trials

Nationwide
Prostate cancer trialsOncology trialsProstate oncology trialsMen's health trialsUrology trials

Related Studies